Mapping Pediatric Oncology Clinical Trial Collaborative Groups on the Global Stage

Ajay Major1, Monica Palese2, Ebru Ermis2

  • 1Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL.

JCO Global Oncology
|February 14, 2022
PubMed

Insights

Global pediatric cancer research collaboration requires tailored strategies, recognizing diverse regional needs and structures. A nuanced approach, incorporating local insights and grassroots efforts, is essential for advancing the WHO Global Initiative for Childhood Cancer.

Area of Science:

  • Pediatric Oncology
  • Global Health
  • Clinical Research Collaboration

Background:

  • The global pediatric oncology landscape, especially in high-burden regions like Africa, Asia, and Central/South America, is under-documented.
  • Understanding existing international pediatric cancer clinical trial groups is crucial for global research and data-sharing initiatives.

Purpose of the Study:

  • To review the formation and research pursuits of international pediatric cancer clinical trial groups.
  • To inform global collaborative research efforts aligned with the WHO Global Initiative for Childhood Cancer.

Main Methods:

  • A narrative literature review was conducted on collaborative pediatric cancer clinical research groups across continents.
  • An inventory of these groups was compiled and reviewed by regional and continental leaders.
  • Common structural and research themes among consortia were identified.

Main Results:

  • Significant variability exists in the structure, history, and objectives of international pediatric cancer clinical trial groups.
  • Some regions feature established groups with adapted treatment regimens, while others focus on registry infrastructure via multinational support or partnerships.

Conclusions:

  • A one-size-fits-all approach to international collaboration is ineffective due to varying local needs and resources.
  • Needs assessments, grassroots approaches, twinning relationships, and implementation science are vital for successful global partnerships in pediatric cancer research.
Abstract

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.7K
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
9.5K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.8K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
9
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K